Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 14/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 14/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPY1R | P25929 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19316647 | 0.95 | TSHR (0.39) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL16193204 | 0.89 | TSHR (0.47) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL19316664 | 0.88 | ADRB2 (0.38) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL12019252 | 0.87 | SCN1A (0.47) | TSHRALDH1A1PTGS2SCN1ASCN2A | |
| SCHEMBL19317055 | 0.85 | ADRB2 (0.38) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL12018013 | 0.84 | SCN1A (0.48) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL21422447 | 0.84 | ADRB2 (0.37) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL18949239 | 0.83 | TSHR (0.46) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL2531577 | 0.83 | TSHR (0.56) | TSHRALDH1A1ADRB2ADRB1ADRB3 | |
| SCHEMBL19316662 | 0.82 | PTPN1 (0.45) | TSHRADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170253555-A1 | POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | TOKUYAMA DENTAL CORPORATION (JP) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253555-A1 | POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | H1-0, VMP1, CHRM1 | TSHR 3456/4885ALDH1A1 1350/4885ADRB2 735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.